Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...
Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for ...
BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
News-Medical.Net on MSN2d
GLDH proposed as a more accurate biomarker for liver injury detectionPredictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for ...
Over 10 days, the porcine liver produces bile and porcine albumin, maintains stable blood flow, and shows no signs of ...
Researchers from Critical Path Institute’s Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for detecting liver injury, supporting ...
A gentle blend of pure retinol, squalane, and shea butter, this works to diminish fine lines and wrinkles without the purging ...
The U.S. Food and Drug Administration's (FDA) Biomarker Qualification Program (BQP) is currently reviewing C-Path's Full Qualification Package (FQP) to qualify GLDH as a liver safety biomarker. The ...
Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...
Pembrolizumab and XL888 in advanced CRC showed manageable safety, though limited responses and potential immunomodulatory ...
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price boosted by stock analysts at Mizuho from $212.00 to ...
Kezar Life Sciences (KZR) reported topline results from the PORTOLA Phase 2a clinical trial evaluating zetomipzomib, a selective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback